tradingkey.logo
tradingkey.logo
Pesquisar

TELA Bio Inc

TELA
Adicionar à lista de desejos
0.706USD
-0.034-4.65%
Fechamento 06/26, 16:00ETCotações atrasadas em 15 min
27.91MValor de mercado
PerdaP/L TTM

Mais detalhes de TELA Bio Inc Empresa

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

Informações de TELA Bio Inc

Código da empresaTELA
Nome da EmpresaTELA Bio Inc
Data de listagemNov 08, 2019
CEOKoblish (Antony)
Número de funcionários209
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 08
Endereço1 Great Valley Parkway, Suite 24
CidadeMALVERN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19355
Telefone14843202930
Sitehttps://www.telabio.com/
Código da empresaTELA
Data de listagemNov 08, 2019
CEOKoblish (Antony)

Executivos da empresa TELA Bio Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+55.91%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%

Perguntas frequentes

Quem são os cinco principais acionistas de TELA Bio Inc?

Os cinco principais acionistas de TELA Bio Inc são: Mr. Antony Koblish

Quantas instituições possuem ações da TELA Bio Inc (TELA)?

Em 2026Q1, 163 instituições possuíam ações da TELA Bio Inc, com valor de mercado aproximado de 32.85M, representando 73.39% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -6147477.00.

Qual é a maior fonte de receita da TELA Bio Inc?

Em 2026Q1, o segmento de negócios OviTex gerou a maior receita para TELA Bio Inc, totalizando 51.22M e representando 63.81% da receita total.
KeyAI